Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1/2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 2Barrett Esophagus 2Thyroid Nodule 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms 1Lung Neoplasms 1Hypoxia 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Esophageal Neoplasms 1Cardiotoxicity 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Breast Neoplasm Female 1Adenocarcinoma 1

Interventions

Early Intervention, Educational 13Oxaliplatin 12Radiotherapy 11Fluorouracil 10Exercise 10Counseling 10Methods 8Surgical Procedures, Operative 7Neoadjuvant Therapy 7Drug Therapy 7Magnetic Resonance Spectroscopy 6Laparoscopy 6Capecitabine 6Surveys and Questionnaires 5Standard of Care 5Proctectomy 5Preoperative Exercise 5Leucovorin 5Psychiatric Rehabilitation 4Fluorodeoxyglucose F18 4Chemotherapy, Adjuvant 4Blood Specimen Collection 4Biopsy 4Bevacizumab 4X-Rays 3Transanal Endoscopic Surgery 3Robotic Surgical Procedures 3Mastectomy, Segmental 3Irinotecan 3Ileostomy 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Rectal Neoplasms × Diagnostic Imaging × Clear all
NCT02640586 2023-06-22

Predicting Neoadjuvant Therapy Response of Rectal Cancer With MRI

Peking University Cancer Hospital & Institute

Phase NA Unknown
1,614 enrolled
Gastrointestinal

Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡